Compound ID | 819
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | 50S ribosomal subunit inhibitor; this series generally showed lower MICS against S. aureus and enterococcal isolates |
| Description: | Lawrence L, Sutcliffe J. In vitro activity of designer oxazolidinones against respiratory pathogens. 45th-Intersci-Conf-Antimicrob-Agents-Chemother 2005;198. |
| Institute where first reported: | Rib-X Pharmaceuticals (Melinta Therapeutics, USA) |
| Year first mentioned: | 2005 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: |